Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Angiojet Rheolytic Thrombectomy in The Management of Iliofemoral Deep Venous Thrombosis

NCT06341010 is registered in ClinicalTrials.gov with Abdelrahman Ibrahim Sayed Mohamed Abdalla as lead sponsor.

NCT NCT06341010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06341010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Angiojet Rheolytic Thrombectomy in The Management of Iliofemoral Deep Venous Thrombosis
Lead sponsor
Abdelrahman Ibrahim Sayed Mohamed Abdalla
Phase
Observational
Overall status
Recruiting
Start date
May 1, 2024
Completion date
September 1, 2026
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iliofemoral deep vein thrombosis